Item 5.01 Change in Control of Registrant.
On August 12, 2020, Yosef Yafe ( the "Seller") and Yuantong Wang (the "Buyer")
entered into a stock purchase agreement (the "SPA"), pursuant to which the
Seller agreed to sell and the Buyer agreed to purchase an aggregate of
31,000,000 shares of common stock, par value $001 per share (of Adaiah
Distribution, Inc. ("Adaiah") from the Seller for an aggregate purchase price of
$300,000. The closing of the transactions contemplated by the SPA occurred on
August 14, 2020. The purchase price was paid out of the Buyer's personal funds.
As of the date referenced in this action, Adaiah had 31,518,466 shares of common
stock outstanding. The securities purchased pursuant to the SPA represent 98.0%
of the outstanding shares of common stock and 98.0% of the voting power of
Adaiah.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain officers; Compensatory Arrangements of Certain Officers.
As contemplated by the SPA, Yosef Yafe resigned as Chairman, Chief Executive
Officer, President, Chief Financial Officer and Secretary of Adaiah and Yuantong
Wang was appointed a director, Chief Executive Officer and President of Adaiah,
effective August 14, 2020. Pursuant to the SPA, Mr. Yafe will resign as a
director of the Company upon compliance by Adaiah with information statement
delivery requirements pursuant to Rule 14f-1 under the Securities Exchange Act
of 1934, as amended.
Yuantong Wang, 52, has been Chief Executive Officer of Guangzhou Huaizhong
Health Technology Co., Ltd since October 2015. From December 2011 to September
2015 he served as the General Manager of Beijing Hengyikang Industry and Trade
Co., Ltd. He earned a Diploma for Higher Education with a major in Library and
Information Science from Tianjin Business School in 1989.
The foregoing changes to Adaiah's management and board of directors were in
connection with the transactions consummated pursuant to the SPA and were not
due to any disagreement with Adaiah on any matter relating to its operations,
policies or practices.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description
10.1 Stock Purchase Agreement, dated as of August 12, 2020
1
© Edgar Online, source Glimpses
HUAIZHONG HEALTH GROUP, INC. 
